Market Segmentation 

The arrhythmia monitoring devices market has been segmented into device type, application, and end-user. Based on the segment which is device type, the market is categorized on the basis of event monitor, Holter monitor, resting ECG, and others. The global market for arrhythmia monitoring devices is further segmented based on application into tachycardia, bradycardia, and others. Furthermore, the market, on the basis of end-user is segmented into hospitals and clinics, and others. 

The global market research report covers all the aspects of the market based on the segmental analysis of these device type, application, and end-user segments. Analysts have also studied the global market's regional markets spread across many continents and countries. The device type, application, and end-user segments along with their sub-segments have been analyzed and companies functioning in the market across these segments are profiled and analyzed based on input and feedback from market based decision makers as well as primary and secondary sources. The market research report presents analysis based information for companies functioning in the market. 

Regional Overview 

High expenses associated with remote cardiac arrhythmia monitoring may hinder the market growth. The market research report suggests that companies in the market could be supported by innovation in product as well as the on-going technical development during the forecast period. The market is set to register growth at a high CAGR owing to these key factors. The market is spread across North America, Europe, Asia-Pacific, and other parts of the world. The global market research report reveals that APAC, North America, and Europe regional arrhythmia monitoring devices markets will dominate the global market for arrhythmia monitoring devices during the forecast period 2016 to 2024. As per arrhythmia monitoring devices market analysts, the market is set to witness tremendous growth across Holter monitor, tachycardia, and hospitals and clinics segments in North America which covers arrhythmia monitoring devices markets across the United States, Canada, Mexico and several other regional markets. Companies active in the market are also analyzed and studied in the arrhythmia monitoring devices market research report. 

The market for Europe covers smaller market segments of Germany, Italy, France, and the United Kingdom. Additionally, the market research report covers the Asia-Pacific region covering markets from India, China, Japan, Australia, and others. The market is also spread across the rest of the world. The market report covers all such regions including the Middle East, Africa, Brazil, and others. 

Competitive Landscape 

Arrhythmia monitoring devices has seen increased demand over the years, due to the high accuracy and efficiency provided by arrhythmia detection and the growing requirement for continuous cardiac rhythm monitoring. Companies functioning in the global arrhythmia monitoring devices market are also being challenged due to the rise in recalls of arrhythmia monitoring devices and cost and budget related concerns among SMEs. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period 2016 to 2024. As the market is set to register a high CAGR of 6.44% and is also anticipated to reach a USD 8,087.4 million by 2024, the report highlights key areas companies need to focus on. The report suggests that the market will see a healthy growth in the long run till 2024. Based on SWOT analysis and market’s analysis based on Porters’ Five Force Model presented in the market report. Mergers and acquisitions by market companies are anticipated to help the market during the forecast period 2016 to 2024.  

Industry News 

This year, the Marlborough, Massachusetts-based medical technology corporation increased its heart device acquisitions, taking a $90 million equity interest in valve treatment business Millipede and purchasing the remaining stock of ablation remote monitoring manufacturer Securus Medical Group for $40 million.  Anti-arrhythmic medications or cardiac ablation, where in radiofrequency or cryothermal energy is applied to regions of the heart responsible for the disturbed heart rhythm, are often used to care for patients with heart failure, a common type of erratic heartbeat. Atrial fibrillation affects at least 2.7 million Americans, increasing the risk of blood clots and stroke.